BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue RestorationContributed by: Business WireLogoImagesEmeraNova seeks partners around the world to bring promising technologies to market quickly and equip clinicians with advanced, effective solutions.EmeraNova represents a vision to pursue emerging (Emer) and new (Nova) technologies.The company’s ever-evolving toolbox model represents its key product areas: Assess & Differentiate, Diagnose, Debride, Control, Prepare, Restore & Regenerate, Reassess, and Remodel Tissue.TagsMedical DevicesHealthHealth TechnologyOther HealthGeneral HealthBiotechnologyEmeraNova
